HCA vs MRSN · P/E 17, rev $75.60B vs rev $40.5M
HCA Holdings Inc (HCA) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
HCA currently screens at market cap $91.01B and trailing P/E 16.8. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the HCA and MRSN stock pages for the full models.
Not investment advice.